Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/15/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Sanja Selak

Wrong Dr. Sanja Selak?

Chief Executive Officer

Phone: +43 **********  
Email: s***@***.com
Local Address:  Vienna , Austria
Origimm e.U.

Employment History

Board Memberships and Affiliations


  • PhD degree , neuroimmunology
26 Total References
Web References
One Nucleus: Origimm e.U. [cached]
Origimm was founded by Dr. Sanja Selak, the former Head of the Department of Serology and Immune Assays at Intercell in 2012.
Origimm was founded by ... [cached]
Origimm was founded by Dr. Sanja Selak, the former Head of the Department of Serology and Immune Assays at Intercell in 2012.
Customer Research Case Studies | ProImmune [cached]
Sanja Selak, Intercell AG
Customer Research Case Studies | ProImmune [cached]
Sanja Selak, Intercell AG
Developing Effective Vaccine Strategies at Intercell | ProImmune [cached]
Dr. Sanja Selak (front row, second from left) and the Serology and Immune Assays team at Intercell AG, Austria.
Epitope discovery systems, such as ProImmune's Antigen Characterization Platform, often identify a large number of candidate epitope sequences. While many protein sequences can potentially be antigenic only a few will be relevant as key antigens with addressable immune responses in vivo. To complicate matters further, the available antigens from pathogens may alter over the course of an infection, as Dr. Sanja Selak of Intercell AG, Austria, outlined in her presentation at ProImmune's Antigen Characterization and Biomarker Discovery Summit in January 2011.
Dr. Selak is investigating the B cell epitopes of pathogenic bacteria, and their potential for use in vaccination strategies. Bacterial antigens are especially tricky to work with because bacteria do not express the same proteome consistently. They react to their environment, in particular the availability of micronutrients, and respond by expressing the cellular machinery they require to survive, so that a whole gamut of new antigens can suddenly become available. She has to consider not only the 'who' of candidate epitopes from her discovery strategies, but the 'when' 'where' and 'why', as bacteria adapt to survive in their local habitat.
Since animal models are of limited value with such well-adapted human pathogens, Dr. Selak and her colleagues are now beginning to consider the potential offered by tissue explant cultures for simulation of bacterial microenvironment during infection.
Watch and listen to a slidecast of Sanja Selak's presentation at the ProImmune Antigen Characterization and Biomarker Discovery Summit
Other People with the name "Selak":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.